Shenzhen Hepalink Pharmaceutical Group. (9989.HK) Q2 2024 Earnings

29AprConfirmed
Q1 2023
Q2 2023
Q3 2023
Q2 2024
0
0.06
0.11
0.17

Details

Expected EPS
N/A
Actual EPS
0.1145055334108
Surprise EPS
0.11
Surprise Percent
+∞%

Description

Shenzhen Hepalink Pharmaceutical Group. (9989.HK) has reported earnings of 0.1145055334108 per share for Q2 2024.

0 Comments

Share your thoughts